GILD
Gilead Sciences Inc.
$126.31
▲ +1.62%
+$2.01
NASDAQ · Technology · Biotechnology
Gilead Sciences Inc.
GILD · NASDAQ · Technology · Biotechnology
$126.31
▲ +1.62% · +$2.01 today
fundamentals74.2 /100 vs peers
solid
Revenue growth (TTM)3.8
73% below Sector 5Y avg avgSector 5Y avg: 14.0
EPS growth (TTM)55.0
377% above Sector 5Y avg avg · favorableSector 5Y avg: 11.5
EPS forecast (5Y)8.9
38% below Sector fwd avg avgSector fwd avg: 14.3
EPS next year3577.44
strong pace
EPS growth (Q/Q)54.3
strong pace
Compared against sector peers where available.
vs sector peers
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| GILDGilead Sciences Inc. | $156.82B | 17.2 | +3.5% | 74 |
| INDVIndivior | $4.59B | 19.1 | -0.3% | 84 |
| LLYEli Lilly and Company | $1.14T | 43.5 | +47.4% | 83 |
| DXCMDexcom | $28.11B | 31.2 | +16.1% | 76 |
| GMEDGlobus Medical | $10.85B | 18.6 | +23.5% | 76 |
